Back to News >

24th July 2024 | Free of charge | Online | 12:00 BST | Duration: 1 hour.

Overview
The webinar will discuss the Continuous Direct Compression (CDC) process and its digital twin technology, highlighting the significant benefits of CDC, including a reduction in the number of experiments and the amount of active pharmaceutical ingredients (APIs) required.

The digital twin enables predictive modelling and machine learning, optimising production processes and reducing environmental impact.

The case study presented indicates up to a 92-ton CO2 equivalent reduction per drug candidate in R&D settings and further benefits in commercial production, such as fewer processing steps, smaller equipment footprints, and overall energy savings.

Speaker
Patryk Kujawa, Technical Specialist, Medicines Manufacturing Innovation Centre
Patryk is a technical specialist at MMIC with nearly three years of experience, where he has been instrumental in advancing the GC1 line. His role focuses on enhancing digital capabilities, integrating sustainability features, and upgrading containment measures. Prior to MMIC, Patryk served as a senior production scientist at Sartorius, leading GMP cell bank manufacturing.

Patryk’s career highlights his dedication to driving process improvements and innovation in pharmaceutical manufacturing, showcasing his expertise in both technical leadership and project management within the industry.

The material presented in this webinar has not been peer-reviewed. Any opinions are the presenter’s own and do not necessarily represent those of IChemE or the Pharma Special Interest Group. The information is given in good faith but without any liability on the part of IChemE.

For more information and to register, please click the link below.

External URL: https://www.icheme.org/knowledge-networks/communities/special-interest-groups/pharma/events/24-07-2024-benefits-of-cdc-process-and-its-digital-twin/